AI주식인사이트AI Stock Insight
B

대웅

003090KOSPI

61.5 / 100

Reference Date: 2026-10-23

Financial Score34.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers and PBR is significantly undervalued vs. peers is also solid. Declined 5.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Dae Woong Co., Ltd., a global healthcare group holding company, reported consolidated sales of 2.684 trillion KRW in 2025, a 6.8% increase from the previous year, though operating profit declined 7.1% to 2.618 billion KRW. Its subsidiary Dae Woong Pharm achieved 13.91 trillion KRW in sales and 2.036 billion KRW in operating profit in 2025, driven by growth in key products like Nabohta and Pexuclo, as well as investments in R&D and digital healthcare initiatives.

Number of Employees

413people

Average Salary

69.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
3.81Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.49Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
13.94Industry Average 8.005.5Point

1.7x industry avg (good)

Debt Ratio
39.33Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲6.8% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲18.5% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 10.9% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 14,920Won52-week high 29,35052-week low 14,920
1-month return2.0Point

1m -5.81% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0